These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


907 related items for PubMed ID: 23098797

  • 1. Role of BDNF/TrkB signaling in antidepressant-like effects of a group II metabotropic glutamate receptor antagonist in animal models of depression.
    Koike H, Fukumoto K, Iijima M, Chaki S.
    Behav Brain Res; 2013 Feb 01; 238():48-52. PubMed ID: 23098797
    [Abstract] [Full Text] [Related]

  • 2. Involvement of the mammalian target of rapamycin signaling in the antidepressant-like effect of group II metabotropic glutamate receptor antagonists.
    Koike H, Iijima M, Chaki S.
    Neuropharmacology; 2011 Dec 01; 61(8):1419-23. PubMed ID: 21903115
    [Abstract] [Full Text] [Related]

  • 3. The VGF-derived peptide TLQP62 produces antidepressant-like effects in mice via the BDNF/TrkB/CREB signaling pathway.
    Lin P, Wang C, Xu B, Gao S, Guo J, Zhao X, Huang H, Zhang J, Chen X, Wang Q, Zhou W.
    Pharmacol Biochem Behav; 2014 May 01; 120():140-8. PubMed ID: 24631486
    [Abstract] [Full Text] [Related]

  • 4. Role of AMPA receptor stimulation and TrkB signaling in the antidepressant-like effect of ketamine co-administered with a group II mGlu receptor antagonist, LY341495, in the forced swim test in rats.
    Pałucha-Poniewiera A, Podkowa K, Pilc A.
    Behav Pharmacol; 2019 Sep 01; 30(6):471-477. PubMed ID: 30724804
    [Abstract] [Full Text] [Related]

  • 5. BDNF signaling is necessary for the antidepressant-like effect of naringenin.
    Yi LT, Liu BB, Li J, Luo L, Liu Q, Geng D, Tang Y, Xia Y, Wu D.
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan 03; 48():135-41. PubMed ID: 24121063
    [Abstract] [Full Text] [Related]

  • 6. Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.
    Liu WX, Wang J, Xie ZM, Xu N, Zhang GF, Jia M, Zhou ZQ, Hashimoto K, Yang JJ.
    Psychopharmacology (Berl); 2016 Feb 03; 233(3):405-15. PubMed ID: 26514555
    [Abstract] [Full Text] [Related]

  • 7. Involvement of AMPA receptor in both the rapid and sustained antidepressant-like effects of ketamine in animal models of depression.
    Koike H, Iijima M, Chaki S.
    Behav Brain Res; 2011 Oct 10; 224(1):107-11. PubMed ID: 21669235
    [Abstract] [Full Text] [Related]

  • 8. The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice.
    Lindholm JS, Autio H, Vesa L, Antila H, Lindemann L, Hoener MC, Skolnick P, Rantamäki T, Castrén E.
    Neuropharmacology; 2012 Jan 10; 62(1):391-7. PubMed ID: 21867718
    [Abstract] [Full Text] [Related]

  • 9. Requirement of AMPA receptor stimulation for the sustained antidepressant activity of ketamine and LY341495 during the forced swim test in rats.
    Koike H, Chaki S.
    Behav Brain Res; 2014 Sep 01; 271():111-5. PubMed ID: 24909673
    [Abstract] [Full Text] [Related]

  • 10. Serotonin-1A receptor stimulation mediates effects of a metabotropic glutamate 2/3 receptor antagonist, 2S-2-amino-2-(1S,2S-2-carboxycycloprop-1-yl)-3-(xanth-9-yl)propanoic acid (LY341495), and an N-methyl-D-aspartate receptor antagonist, ketamine, in the novelty-suppressed feeding test.
    Fukumoto K, Iijima M, Chaki S.
    Psychopharmacology (Berl); 2014 Jun 01; 231(11):2291-8. PubMed ID: 24402133
    [Abstract] [Full Text] [Related]

  • 11. The group II mGlu receptor antagonist LY341495 induces a rapid antidepressant-like effect and enhances the effect of ketamine in the chronic unpredictable mild stress model of depression in C57BL/6J mice.
    Pałucha-Poniewiera A, Podkowa K, Rafało-Ulińska A.
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jul 13; 109():110239. PubMed ID: 33400944
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Group II mGlu receptor antagonist LY341495 enhances the antidepressant-like effects of ketamine in the forced swim test in rats.
    Podkowa K, Pochwat B, Brański P, Pilc A, Pałucha-Poniewiera A.
    Psychopharmacology (Berl); 2016 Aug 13; 233(15-16):2901-14. PubMed ID: 27286960
    [Abstract] [Full Text] [Related]

  • 14. [The potential of group II metabotropic glutamate receptor antagonists as a novel antidepressant].
    Chaki S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug 13; 32(4):219-26. PubMed ID: 23012890
    [Abstract] [Full Text] [Related]

  • 15. The antidepressant-like effects of the water extract of Panax ginseng and Polygala tenuifolia are mediated via the BDNF-TrkB signaling pathway and neurogenesis in the hippocampus.
    Jiang N, Wang H, Li C, Zeng G, Lv J, Wang Q, Chen Y, Liu X.
    J Ethnopharmacol; 2021 Mar 01; 267():113625. PubMed ID: 33248184
    [Abstract] [Full Text] [Related]

  • 16. The antidepressant-like effects of biperiden may involve BDNF/TrkB signaling-mediated BICC1 expression in the hippocampus and prefrontal cortex of mice.
    Zhou D, Zhang Z, Liu L, Li C, Li M, Yu H, Cai X, Sun X, Shen X, Wang J, Geng J, Wang C, Shi Y.
    Pharmacol Biochem Behav; 2017 Jun 01; 157():47-57. PubMed ID: 28216067
    [Abstract] [Full Text] [Related]

  • 17. The Rapidly Acting Antidepressant Ketamine and the mGlu2/3 Receptor Antagonist LY341495 Rapidly Engage Dopaminergic Mood Circuits.
    Witkin JM, Monn JA, Schoepp DD, Li X, Overshiner C, Mitchell SN, Carter G, Johnson B, Rasmussen K, Rorick-Kehn LM.
    J Pharmacol Exp Ther; 2016 Jul 01; 358(1):71-82. PubMed ID: 27189960
    [Abstract] [Full Text] [Related]

  • 18. Activity-Dependent Brain-Derived Neurotrophic Factor Release Is Required for the Rapid Antidepressant Actions of Scopolamine.
    Ghosal S, Bang E, Yue W, Hare BD, Lepack AE, Girgenti MJ, Duman RS.
    Biol Psychiatry; 2018 Jan 01; 83(1):29-37. PubMed ID: 28751069
    [Abstract] [Full Text] [Related]

  • 19. Activation of hippocampal BDNF signaling is involved in the antidepressant-like effect of the NMDA receptor antagonist 7-chlorokynurenic acid.
    Li CF, Chen XM, Chen SM, Mu RH, Liu BB, Luo L, Liu XL, Geng D, Liu Q, Yi LT.
    Brain Res; 2016 Jan 01; 1630():73-82. PubMed ID: 26562663
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 46.